Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113024565B details a stable C-14 ibrutinib synthesis. Enhance environmental safety research with high-purity radiochemical intermediates and scalable production.
Patent CN103553857A reveals a photocatalytic method for direct ortho-trifluoromethylation. Discover cost reduction in fine chemical manufacturing and scalable supply solutions.
Patent CN101575319A details a greener route for Lapatinib intermediates, eliminating toxic chlorinating agents for significant cost reduction and supply chain reliability.
Advanced zinc-complexation method for high-purity 3-N-ethyl Gentamicin C1a. Reduces impurities and enhances supply chain reliability for Etimicin production.
Patent CN107365300A details a novel salt formation technique for Lansoprazole. This method ensures high purity and yield while offering substantial supply chain and cost advantages for global buyers.
Patent CN111116688B reveals a mild phosphoric acid method for Prazomicin. Achieve high purity and cost reduction in antibiotic manufacturing with scalable processes.
Novel chemical refining method for Isepamicin avoids chromatography ensuring high purity and supply stability for pharmaceutical manufacturing partners.
Novel silica gel chromatography method ensures high purity homoharringtonine. Significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN1798759A reveals a novel allylation-Peterson elimination route for high-purity Cyclosporin A analogues, offering significant supply chain and cost advantages.
Discover the advanced synthesis of NOBIN-type axial chiral biaryl compounds via patent CN116535329B. Offers high enantioselectivity, metal-free catalysis, and scalable manufacturing for global pharmaceutical supply chains.
Advanced synthesis of Rilpivirine intermediates via patent CN103183642A. Delivers high purity and scalable routes for cost-effective API manufacturing.
Discover a novel DCC/DMAP catalyzed method for Ceftizoxime Sodium production. Eliminate toxic residues and achieve 99% purity for reliable pharmaceutical supply chains.
This report analyzes patent CN102584855A for ceftiofur production offering high purity and scalable methods for reliable veterinary drug supply chains.
Patent CN103992306A details an improved Sharpless oxidation for S-Pantoprazole Sodium offering high purity and cost-effective manufacturing for global supply chains.
Patent CN105859747A reveals a low-cost anhydrous refining process for high-purity Cefepime, ensuring supply chain stability and reduced manufacturing expenses.
Advanced synthesis method for dapagliflozin intermediates offering enhanced purity and streamlined processing for reliable pharmaceutical supply chains.
Novel 9-step synthesis for deoxycholic acid intermediates. Reduces steps, increases yield to 31.5%. Ideal for pharmaceutical supply chains and cost reduction.
Patent CN106866707B reveals catalyst-free synthesis for benzimidazolo thiazole derivatives offering significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN1039906C reveals advanced etherification and cyclization routes for CNS drug intermediates, offering scalable production and cost efficiency for pharmaceutical supply chains.
Patent CN103965293B reveals a novel ethyl acetate washing method for bivalirudin. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.